Evidence map›Paper›PMID 40711749›Full record

GuidelineAnnals of nuclear medicine2025

Clinical Practice Guidelines for

Kimiteru Ito, Seishi Jinnouchi, Kaoru Kikukawa, Chio Okuyama, Yoshifumi Sugawara, Masami Kawamoto, Koichi Koyama, Kanae Kawai Miyake, Koji Murakami

Abstract readPractice GuidelineReview
PubMed Full text at PMC Publisher
In one paragraph

Guideline in Annals of nuclear medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Physiological biodistribution ofFrontiers in nuclear medicine · 2026
    Article
  2. Surgical neurology international · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kimiteru ItoDepartment of Diagnostic Radiology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan. kimito@ncc.go.jp.ORCID http://orcid.org/0000-0003-0905-6767
Seishi JinnouchiDepartment of Radiology, Atsuchi Memorial Clinic PET Center, 12-1 Terukuni-Cho, Kagoshima, 892-0841, Japan.
Kaoru KikukawaDepartments of Radiology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan.
Chio OkuyamaClinical Research Center, Shiga General Hospital, 5-4-30, Moriyama-Cho, Moriyama, Shiga, 524-8524, Japan.
Yoshifumi SugawaraDepartment of Diagnostic Radiology, National Hospital Organization, Shikoku Cancer Center, Minamiumemotomachi Kou 160, Matsuyama, Ehime, 791-0280, Japan.
Masami KawamotoAdvanced Medical Center, Shonan Kamakura General Hospital, 13701, Okamoto, Kamakura, Kanagawa, 247-8533, Japan.
Koichi KoyamaPET Center, Osaka Saiseikai Nakatsu Hospital, 2-10-39 Shibata, Kita-Ku, Osaka, 530-0012, Japan.
Kanae Kawai MiyakeDepartment of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, 54 Kawahara-Cho, Shogoin, Sakyo-Ku, Kyoto, 606-8507, Japan.
Koji MurakamiDepartment of Radiology, Juntendo University Hospital, 3-1-3, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carboxylic AcidsCyclobutanesNuclear MedicineSocieties, MedicalEast Asian PeopleHumansJapanPositron-Emission TomographyCarboxylic AcidsCyclobutanesfluciclovine F-1818F-FluciclovineAxumin™FACBCGliomaSurgical margin

Identifiers

PMID40711749
PMCPMC12378485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.